In turn, Chen et al., reported lower RECK gene expression levels in prostate tumor cells compared with the expression in adjacent healthy cells using qRT-PCR and identified RECK as a target for miR-15b, a miRNA with oncogenic potential. This evidence concerns the gene RECK and prostate neoplasm.